SCHEMBL21733233

SCHEMBL21733233

CCN1CC(OC)C(OC)C1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EHMT2 Q96KQ7 1/20 0.33
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15317978 1.00 EHMT2 (0.33) EHMT2KDM4E
SCHEMBL23640813 1.00 EHMT2 (0.33) EHMT2KDM4E
SCHEMBL21216134 0.85
SCHEMBL2680066 0.84 EHMT2 (0.30) EHMT2
SCHEMBL22446857 0.84 GLB1 (0.36) EHMT2
SCHEMBL15317972 0.84 GLB1 (0.36) EHMT2
SCHEMBL21195989 0.84 GLB1 (0.36) EHMT2
SCHEMBL3716254 0.84 EHMT2 (0.30) EHMT2
SCHEMBL21210789 0.80 EHMT2 (0.39) EHMT2KDM4E
SCHEMBL15134058 0.79 GBA1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200054645-A1 FLUORO BETA-CARBOLINE COMPOUNDS OSSIFI THERAPEUTICS LLC 2020-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200054645-A1 FLUORO BETA-CARBOLINE COMPOUNDS GLS, AFF1, SLC5A1 EHMT2 2698/4885KDM4E 2421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.